文献速递帕金森病与运动障碍认知障碍与痴呆神经免疫

特发性/孤立性快速眼动睡眠行为障碍队列中运动与非运动特征的演变

Evolution of Motor and Nonmotor Characteristics in an Idiopathic/Isolated REM Sleep Behavior Disorder Cohort.
PubMed 文献 · Neurology · 2025-09-08

这项前瞻性队列研究纳入95例多导睡眠图证实的特发性/孤立性快速眼动睡眠行为障碍(iRBD)患者,随访至转化为帕金森病、路易体痴呆或多系统萎缩,回溯分析转化前14年的临床轨迹。结果显示运动和非运动损害在诊断前多年已出现,部分特征早期出现并线性进展,另一些在转化前数年加速恶化;帕金森病与路易体痴呆转化者的认知和色觉轨迹不同。

要点

  • iRBD患者转化为帕金森病、路易体痴呆或多系统萎缩前多年已出现运动和非运动损害。
  • 运动损害从转化前10年开始缓慢进展,转化前约4年呈指数增长。
  • 路易体痴呆转化者整体认知和色觉下降比帕金森病转化者更快。

核心结论

  • iRBD患者在与年龄匹配的预期轨迹相比,在确诊明确突触核蛋白病前多年已出现运动和非运动损害。
  • 部分临床特征早期出现并线性进展,另一些逐渐发展并在转化前不久加速进展。
  • 帕金森病、多系统萎缩和路易体痴呆转化者临床轨迹重叠但不同,主要体现在运动测试、认知功能和色觉。

研究设计与样本

  • 前瞻性队列研究(2004-2023年),在蒙特利尔高级睡眠医学研究中心纳入多导睡眠图证实的iRBD患者。
  • 共纳入95例iRBD患者,年龄69.0 ± 8.5岁,26%女性,RBD病程7.1 ± 7.4年,随访1-15年。
  • 每年进行综合运动和运动评估,直至满足帕金森病、路易体痴呆或多系统萎缩的临床诊断标准(转化)。
  • 从转化点回溯,使用混合效应模型比较iRBD患者与年龄预期轨迹,以及帕金森病与路易体痴呆转化者之间的临床轨迹。

主要发现

  • 最终诊断为帕金森病46例、路易体痴呆43例、多系统萎缩6例。
  • 转化者中,运动障碍学会统一帕金森病评定量表第三部分和定量运动测试显示从转化前10年(Y-10)开始缓慢进展,转化前约4年呈指数增长(F(4,298) = 79.1,p < 0.001)。
  • 转化前4至5年,整体认知(F(3,278) = 33.7,p < 0.001)和色觉(F(3,646) = 15.9,p < 0.001)加速恶化。
  • 嗅觉减退从转化前14年(Y-14)即明显,并线性进展(F(1,37) = 15.0,p < 0.001);自主神经表现从转化前12年(Y-12)明显。
  • 路易体痴呆转化者整体认知(F(3,95) = 21.0,p < 0.001)和色觉(F(3,235) = 3.5,p = 0.02)下降比帕金森病转化者更快。

临床怎么用

  • iRBD患者应进行长期运动和非运动评估,以识别早期突触核蛋白病前驱表现。
  • 运动测试、认知功能和色觉的纵向变化可能有助于区分帕金森病与路易体痴呆转化轨迹。
  • 早期出现的嗅觉减退和自主神经表现可作为前驱期监测指标。

局限性

  • 需要更多包括对照组纵向随访的大型多中心研究。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVES: Years before diagnosis of Parkinson disease (PD), dementia with Lewy bodies (DLB), or multiple system atrophy (MSA), mild prodromal manifestations can be detected. Longitudinal follow-up of people with prodromal synucleinopathy, particularly idiopathic/isolated REM sleep behavior disorder (iRBD), enables in-depth clinical phenotyping of early disease, which could facilitate stratification for clinical trials, provide the definition of appropriate end points, or predict phenoconversion more precisely. The aim of this study was to update and expand on previous studies assessing clinical evolution from iRBD to clinically diagnosed disease, up to 14 years before diagnosis. METHODS: People with polysomnography-proven iRBD were included in this prospective cohort study (2004-2023) at Center for Advanced Research in Sleep Medicine (Montreal). Participants were followed annually with comprehensive motor and nonmotor assessments until they fulfilled clinical diagnostic criteria for PD, DLB, or MSA ("phenoconversion"). Tracing backward from phenoconversion, clinical trajectories in iRBD were compared with age-expected trajectories, as well as between PD and DLB phenoconverters, using mixed-effects models. RESULTS: A total of 95 people with iRBD were included in the analysis (69.0 ± 8.5 years, 26% female, RBD duration 7.1 ± 7.4 years, follow-up 1-15 years) and were eventually diagnosed with either PD (n = 46), DLB (n = 43), or MSA (n = 6). Among phenoconverters, Movement Disorders Society-Unified Parkinson's Disease Rating Scale Part III and quantitative motor testing showed slowly progressing changes from Y-10, followed by exponential increase approximately 4 years before phenoconversion (F(4,298) = 79.1, p < 0.001). From 4 to 5 years before phenoconversion, accelerated worsening was found in global cognition (F(3,278) = 33.7, p < 0.001) and color vision (F(3,646) = 15.9, p < 0.001). Hyposmia was evident from Y-14 and progressed linearly (F(1,37) = 15.0, p < 0.001). Autonomic manifestations were evident from Y-12. DLB phenoconverters showed faster decline in global cognition (F(3,95) = 21.0, p < 0.001) and color vision (F(3,235) = 3.5, p = 0.02) than PD phenoconverters. DISCUSSION: Participants with iRBD showed evolving motor and nonmotor impairment many years before diagnosis of manifest synucleinopathy compared with estimated age-expected references. Our results suggest that some clinical features emerge early and progress linearly while others develop gradually and progress more rapidly shortly before phenoconversion. Prodromal PD, MSA, and DLB phenoconverters showed overlapping but distinct clinical trajectories, mainly for motor testing, cognitive function, and color vision. Additional large multicenter studies including longitudinal follow-up of controls are needed.

来源:Neurology,查看原文。版权归原作者所有。

引用

  1. Delva A, Fereshtehnejad SM, Vo A, et al. Evolution of Motor and Nonmotor Characteristics in an Idiopathic/Isolated REM Sleep Behavior Disorder Cohort. Neurology. 2025. PMID: 40921020. doi:10.1212/WNL.0000000000214108

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。